Western Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-11,265
| Closed | -$365K | – | 618 |
|
|
2022
Q3 | $365K | Sell |
11,265
-270
| -2% | -$8.75K | 0.02% | 584 |
|
|
2022
Q2 | $362K | Sell |
11,535
-9,484
| -45% | -$298K | 0.02% | 555 |
|
|
2022
Q1 | $966K | Buy |
21,019
+9,710
| +86% | +$446K | 0.05% | 341 |
|
|
2021
Q4 | $692K | Buy |
+11,309
| New | +$692K | 0.07% | 267 |
|
|
2021
Q2 | $910K | Sell |
9,856
-304
| -3% | -$28.1K | 0.09% | 227 |
|
|
2021
Q1 | $901K | Buy |
10,160
+4,154
| +69% | +$368K | 0.12% | 180 |
|
|
2020
Q4 | $560K | Buy |
6,006
+1,050
| +21% | +$97.9K | 0.08% | 233 |
|
|
2020
Q3 | $316K | Buy |
+4,956
| New | +$316K | 0.05% | 327 |
|